col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Elsevier: The Lancet Infectious Diseases
  original article Date Title Authors   All Authors
1 [GO] 2021―Sep―15 Addendum needed on COVID-19 travel study Lee Altenberg
2 [GO] 2021―Sep―15 Addendum needed on COVID-19 travel study - Authors' reply Mathew V Kiang, Elizabeth T Chin, Benjamin Q Huynh, Lloyd A C Chapman, Nathan C Lo
3 [GO] 2021―Sep―15 Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years: a randomised, double-blind, controlled, phase 1/2 trial ShengLi Xia, YunTao Zhang, YanXia Wang, Hui Wang, YunKai Yang, George Fu Gao, et al. (+32)
4 [GO] 2021―Sep―14 Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial Florence Ader, Maude Bouscambert-Duchamp, Maya Hites, Nathan Peiffer-Smadja, Julien Poissy, Drifa Belhadi, et al. (+175)
5 [GO] 2021―Sep―14 India's COVID-19 vaccination drive: key challenges and resolutions Om Prakash Choudhary, Priyanka Choudhary, Indraj Singh
6 [GO] 2021―Sep―14 Prevention of host-to-host transmission by SARS-CoV-2 vaccines Darius Mostaghimi, Caroline N Valdez, Haleigh T Larson, Chaney C Kalinich, Akiko Iwasaki
7 [GO] 2021―Sep―09 Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study Denis Sauré, Miguel O'Ryan, Juan Pablo Torres, Marcela Zuniga, Emilio Santelices, Leonardo J Basso
8 [GO] 2021―Sep―09 Protection against COVID-19: beyond antibodies Marcus Vinícius Guimarães Lacerda, Daniel Youssef Bargieri
9 [GO] 2021―Sep―07 Hospitalisation among vaccine breakthrough COVID-19 infections Prerak V Juthani, Akash Gupta, Kelly A Borges, Christina C Price, Alfred I Lee, Christine H Won, Hyung J Chun
10 [GO] 2021―Sep―03 Hospitalisation associated with SARS-CoV-2 delta variant in Denmark Peter Bager, Jan Wohlfahrt, Morten Rasmussen, Mads Albertsen, Tyra Grove Krause
11 [GO] 2021―Sep―01 Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study Michela Antonelli, Rose S Penfold, Jordi Merino, Carole H Sudre, Erika Molteni, Sarah Berry, et al. (+24)
12 [GO] 2021―Aug―28 Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study Katherine A Twohig, Tommy Nyberg, Asad Zaidi, Simon Thelwall, Mary A Sinnathamby, Shirin Aliabadi, et al. (+602)
13 [GO] 2021―Aug―28 Importance of epidemiological factors in the evaluation of transmissibility and clinical severity of SARS-CoV-2 variants Jérôme R Lechien, Sven Saussez
14 [GO] 2021―Aug―24 Is indiscriminate use of medicines the main reason for problems faced during the second wave of COVID-19 in India? Deepak K Tempe
15 [GO] 2021―Aug―24 Is indiscriminate use of medicines the main reason for problems faced during the second wave of COVID-19 in India? - Authors' reply Zarir Udwadia, Satchit Balsari, Abdul Ghafur
16 [GO] 2021―Aug―24 Testing indicators to monitor the COVID-19 pandemic Julien Beauté, Cornelia Adlhoch, Nick Bundle, Angeliki Melidou, Gianfranco Spiteri
17 [GO] 2021―Aug―24 An imaginary pandemic and its consequences Sanjeet Bagcchi
18 [GO] 2021―Aug―24 Memorialising Trump's pandemic (non-)response Vijay Shankar Balakrishnan
19 [GO] 2021―Aug―16 The association between COVID-19 vaccination and Bell's palsy Nicola Cirillo, Richard Doan
20 [GO] 2021―Aug―16 Persistent SARS-CoV-2 infection: the urgent need for access to treatment and trials Ed Moran, Tim Cook, Anna L Goodman, Ravindra K Gupta, Stephen Jolles, David K Menon, et al. (+5)
21 [GO] 2021―Aug―16 Bell's palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study Eric Yuk Fai Wan, Celine Sze Ling Chui, Francisco Tsz Tsun Lai, Esther Wai Yin Chan, Xue Li, Vincent Ka Chun Yan, et al. (+16)
22 [GO] 2021―Aug―13 COVID-19 vaccine equity and booster doses The Lancet Infectious Diseases
23 [GO] 2021―Aug―13 How reliable are COVID-19 burden estimates for India? You Li, Harish Nair
24 [GO] 2021―Aug―13 SARS-CoV-2 infection and mortality during the first epidemic wave in Madurai, south India: a prospective, active surveillance study Ramanan Laxminarayan, Chandra Mohan B, Vinay T G, K V Arjun Kumar, Brian Wahl, Joseph A Lewnard
25 [GO] 2021―Aug―13 Rapid genome sequencing in hospitals to identify potential vaccine-escape SARS-CoV-2 variants Luke B Snell, Penelope R Cliff, Themoula Charalampous, Adela Alcolea-Medina, Saidat A R T Ebie, Jasveen K Sehmi, et al. (+5)
26 [GO] 2021―Aug―09 Lessons about COVID-19 vaccine hesitancy among minority ethnic people in the UK Seilesh Kadambari, Samantha Vanderslott
27 [GO] 2021―Aug―04 Is oropharyngeal sampling a reliable test to detect SARS-CoV-2? Tobias Todsen, Nikolai Kirkby, Thomas Benfield
28 [GO] 2021―Aug―04 Is oropharyngeal sampling a reliable test to detect SARS-CoV-2? - Authors' reply Nicole Ngai Yung Tsang, Hau Chi So, Dennis Kai Ming Ip
29 [GO] 2021―Aug―02 Understanding why superspreading drives the COVID-19 pandemic but not the H1N1 pandemic Paul Z Chen, Marion Koopmans, David N Fisman, Frank X Gu
30 [GO] 2021―Jul―29 Heterologous prime-boost vaccination with ChAdOx1 nCoV-19 and BNT162b2 Matthias Tenbusch, Sofie Schumacher, Emanuel Vogel, Alina Priller, Jürgen Held, Philipp Steininger, et al. (+22)
31 [GO] 2021―Jul―28 Impact of COVID-19 on migrants and refugees Vijay Shankar Balakrishnan
32 [GO] 2021―Jul―28 Cameroon's bold response to the COVID-19 pandemic during the first and second waves Linda Esso, Emilienne Epée, Chanceline Bilounga, Aristide Abah, Achta Hamadou, Elisabeth Dibongue, et al. (+12)
33 [GO] 2021―Jul―28 Entering a labyrinth of COVID-19 stories Peter Ranscombe
34 [GO] 2021―Jul―27 Images of a world facing a pandemic Marco De Ambrogi
35 [GO] 2021―Jul―26 Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial Shipo Wu, Jianying Huang, Zhe Zhang, Jianyuan Wu, Jinlong Zhang, Hanning Hu, et al. (+14)
36 [GO] 2021―Jul―01 Vaccine hesitancy in the COVID-19 era Bipin Adhikari, Phaik Yeong Cheah
37 [GO] 2021―Jul―01 Old politics in pandemic management Heather MacDougal
38 [GO] 2021―Jun―28 COVID-19 vaccines for children younger than 12 years: are we ready? Xiaohui Zou, Bin Cao
39 [GO] 2021―Jun―28 The SARS-CoV-2 B.1.1.7 variant and increased clinical severity-the jury is out Benjamin Giles, Paul Meredith, Samuel Robson, Gary Smith, Anoop Chauhan
40 [GO] 2021―Jun―28 Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial Bihua Han, Yufei Song, Changgui Li, Wanqi Yang, Qingxia Ma, Zhiwei Jiang, et al. (+9)
41 [GO] 2021―Jun―23 Effectiveness of BNT162b2 and ChAdOx1 nCoV-19 COVID-19 vaccination at preventing hospitalisations in people aged at least 80 years: a test-negative, case-control study Catherine Hyams, Robin Marlow, Zandile Maseko, Jade King, Lana Ward, Kazminder Fox, et al. (+12)
42 [GO] 2021―Jun―23 Global COVID-19 vaccine inequity Talha Burki
43 [GO] 2021―Jun―23 Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study Madhumita Shrotri, Maria Krutikov, Tom Palmer, Rebecca Giddings, Borscha Azmi, Sathyavani Subbarao, et al. (+9)
44 [GO] 2021―Jun―23 Risk of hospitalisation associated with infection with SARS-CoV-2 lineage B.1.1.7 in Denmark: an observational cohort study Peter Bager, Jan Wohlfahrt, Jannik Fonager, Morten Rasmussen, Mads Albertsen, Thomas Yssing Michaelsen, et al. (+10)
45 [GO] 2021―Jun―23 Mortality and critical care unit admission associated with the SARS-CoV-2 lineage B.1.1.7 in England: an observational cohort study Martina Patone, Karen Thomas, Rob Hatch, Pui San Tan, Carol Coupland, Weiqi Liao, et al. (+6)
46 [GO] 2021―Jun―23 Single-dose SARS-CoV-2 vaccination efficacy in the elderly Maria Prendecki, Michelle Willicombe
47 [GO] 2021―Jun―23 SARS-CoV-2 variants and considerations of inferring causality on disease severity Muge Cevik, Sharmistha Mishra
48 [GO] 2021―Jun―23 The eternal cycle of pandemics Genevieve Pascal
49 [GO] 2021―Jun―21 COVID-19 and SOS tweets in India Anuraag Jena
50 [GO] 2021―Jun―10 Should we vaccinate children against SARS-CoV-2? The Lancet Infectious Diseases
51 [GO] 2021―Jun―08 Contextualising evidence-based recommendations for the second wave of the COVID-19 pandemic in India Satchit Balsari, Zarir Udwadia, Ahmed Shaikh, Abdul Ghafur, Sushila Kataria
52 [GO] 2021―Jun―07 Bell's palsy and SARS-CoV-2 vaccines-an unfolding story Nicola Cirillo, Richard Doan
53 [GO] 2021―Jun―07 Bell's palsy and SARS-CoV-2 vaccines-an unfolding story - Authors' reply Al Ozonoff, Etsuro Nanishi, Ofer Levy
54 [GO] 2021―May―28 Negative antigen RDT and RT-PCR results do not rule out COVID-19 if clinical suspicion is strong Fernando Kemta Lekpa, Sylvain Raoul Simeni Njonnou, Eric Balti, Henry Namme Luma, Simeon Pierre Choukem
55 [GO] 2021―May―28 Negative antigen RDT and RT-PCR results do not rule out COVID-19 if clinical suspicion is strong - Authors' reply Nadia Mandeng, Karl Njuwa Fai, Lisa M Bebell, Yap Boum
56 [GO] 2021―May―27 Innovations in COVID-19 testing: the road from pandemic response to control Rosanna W Peeling, David L Heymann
57 [GO] 2021―May―27 Same-day SARS-CoV-2 antigen test screening in an indoor mass-gathering live music event: a randomised controlled trial Boris Revollo, Ignacio Blanco, Pablo Soler, Jessica Toro, Nuria Izquierdo-Useros, Jordi Puig, et al. (+8)
58 [GO] 2021―May―27 Serum neutralising activity against SARS-CoV-2 variants elicited by CoronaVac Yuxin Chen, Han Shen, Rui Huang, Xin Tong, Chao Wu
59 [GO] 2021―May―26 Vaccine development lessons between HIV and COVID-19 Sandhya Vasan, Punnee Pitisuttithum
60 [GO] 2021―May―26 HIV in the age of COVID-19 Talha Burki
61 [GO] 2021―May―25 A prescription for fair housing during the COVID-19 pandemic Syed M Qasim Hussaini
62 [GO] 2021―May―19 What chikungunya teaches us about COVID-19 Fabrice Simon, Hugh Watson, Jean-Baptiste Meynard, Vincent Pommier de Santi, Jean-Nicolas Tournier
63 [GO] 2021―May―19 SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity Muthukumar Ramanathan, Ian D Ferguson, Weili Miao, Paul A Khavari
64 [GO] 2021―May―18 Ongoing and future COVID-19 vaccine clinical trials: challenges and opportunities Rafael Dal-Ré, Linda-Gail Bekker, Christian Gluud, Søren Holm, Vivekanand Jha, Gregory A Poland, et al. (+6)
65 [GO] 2021―May―14 The rocky road to universal COVID-19 vaccination The Lancet Infectious Diseases
66 [GO] 2021―May―11 Applying prospective genomic surveillance to support investigation of hospital-onset COVID-19 William L Hamilton, Tom Fieldman, Aminu Jahun, Ben Warne, Christopher J R Illingworth, Chris Jackson, et al. (+37)
67 [GO] 2021―May―11 Post-acute conditions of patients with COVID-19 not requiring hospital admission Lixue Huang, Bin Cao
68 [GO] 2021―May―11 Post-acute effects of SARS-CoV-2 infection in individuals not requiring hospital admission: a Danish population-based cohort study Lars Christian Lund, Jesper Hallas, Henrik Nielsen, Anders Koch, Stine Hasling Mogensen, Nikolai Constantin Brun, et al. (+3)
69 [GO] 2021―May―04 SARS-CoV-2 rapid antigen detection tests Sotirios Fouzas
70 [GO] 2021―May―04 SARS-CoV-2 rapid antigen detection tests Thomas Weitzel, Caricia Pérez, Danixa Tapia, Paulette Legarraga, Lorena Porte
71 [GO] 2021―May―04 SARS-CoV-2 rapid antigen detection tests - Authors' reply Rosanna W Peeling, Piero Olliaro, Debrah Boeras, Noah Fongwen
72 [GO] 2021―Apr―27 Symptom study app provides real-world data on COVID-19 vaccines Ruth E Drury, Daniel O'Connor
73 [GO] 2021―Apr―27 Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study Cristina Menni, Kerstin Klaser, Anna May, Lorenzo Polidori, Joan Capdevila, Panayiotis Louca, et al. (+22)
74 [GO] 2021―Apr―23 Bilateral infiltrates in a health-care worker during the COVID-19 pandemic Otmar Schindler, Gerald Steiner, Elisabeth Trattner, Eva Schmon, Wolfgang Kuebler, Eveline Kink
75 [GO] 2021―Apr―23 CEPI prepares for future pandemics and epidemics Udani Samarasekera
76 [GO] 2021―Apr―20 COVID-19 herd immunity by immunisation: are children in the herd? Stephen Obaro
77 [GO] 2021―Apr―20 Recombinant protein vaccines against SARS-CoV-2 Sarah C Gilbert, Teresa Lambe
78 [GO] 2021―Apr―20 Safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine formulations in healthy adults: interim results of a randomised, placebo-controlled, phase 1-2, dose-ranging study Paul A Goepfert, Bo Fu, Anne-Laure Chabanon, Matthew I Bonaparte, Matthew G Davis, Brandon J Essink, et al. (+16)
79 [GO] 2021―Apr―20 Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial Keith J Chappell, Francesca L Mordant, Zheyi Li, Danushka K Wijesundara, Paula Ellenberg, Julia A Lackenby, et al. (+29)
80 [GO] 2021―Apr―15 SARS-CoV-2 incidence and vaccine escape Robin N Thompson, Edward M Hill, Julia R Gog
81 [GO] 2021―Apr―15 Lowering SARS-CoV-2 viral load might affect transmission but not disease severity in secondary cases Mattia Trunfio, Andrea Calcagno, Stefano Bonora, Giovanni Di Perri
82 [GO] 2021―Apr―15 Lowering SARS-CoV-2 viral load might affect transmission but not disease severity in secondary cases - Authors' reply Matthew A Spinelli, George Rutherford, Monica Gandhi
83 [GO] 2021―Apr―14 Beyond COVID-19-will self-sampling and testing become the norm? Yap Boum, Sara Eyangoh, Marie-Claire Okomo
84 [GO] 2021―Apr―14 Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study Dan Frampton, Tommy Rampling, Aidan Cross, Heather Bailey, Judith Heaney, Matthew Byott, et al. (+23)
85 [GO] 2021―Apr―14 Diagnostic performance of different sampling approaches for SARS-CoV-2 RT-PCR testing: a systematic review and meta-analysis Nicole Ngai Yung Tsang, Hau Chi So, Ka Yan Ng, Benjamin J Cowling, Gabriel M Leung, Dennis Kai Ming Ip
86 [GO] 2021―Apr―14 Lack of detail in population-level data impedes analysis of SARS-CoV-2 variants of concern and clinical outcomes Sean Wei Xiang Ong, Barnaby Edward Young, David Chien Lye
87 [GO] 2021―Apr―09 “In an ocean of ashes, islands of order”: WHO's SARS-CoV-2 origin report The Lancet Infectious Diseases
88 [GO] 2021―Apr―01 The interplay between COVID-19 restrictions and vaccination Chad R Wells, Alison P Galvani
89 [GO] 2021―Apr―01 Prioritising COVID-19 vaccination in changing social and epidemiological landscapes: a mathematical modelling study Peter C Jentsch, Madhur Anand, Chris T Bauch
90 [GO] 2021―Mar―25 Rolling out COVID-19 antigen rapid diagnostic tests: the time is now Rosanna W Peeling, Piero Olliaro
91 [GO] 2021―Mar―25 The effect of seasonal respiratory virus transmission on syndromic surveillance for COVID-19 in Ontario, Canada Arjuna S Maharaj, Jennifer Parker, Jessica P Hopkins, Effie Gournis, Isaac I Bogoch, Benjamin Rader, et al. (+8)
92 [GO] 2021―Mar―25 Performance and operational feasibility of antigen and antibody rapid diagnostic tests for COVID-19 in symptomatic and asymptomatic patients in Cameroon: a clinical, prospective, diagnostic accuracy study Yap Boum, Karl Njuwa Fai, Birgit Nicolay, Akenji Blaise Mboringong, Lisa M Bebell, Mark Ndifon, et al. (+23)
93 [GO] 2021―Mar―24 Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials Shilong Yang, Yan Li, Lianpan Dai, Jianfeng Wang, Peng He, Changgui Li, et al. (+23)
94 [GO] 2021―Mar―24 Ebola and COVID-19 in DR Congo and Guinea Paul Adepoju
95 [GO] 2021―Mar―24 COVID-19 vaccination in Ukraine Edward Holt
96 [GO] 2021―Mar―24 Is there space for a three-dose vaccine to fight the spread of SARS-CoV-2? Patrick L Iversen, Sina Bavari
97 [GO] 2021―Mar―24 Behind Cuba's successful pandemic response Talha Burki
98 [GO] 2021―Mar―23 Routine asymptomatic testing strategies for airline travel during the COVID-19 pandemic: a simulation study Mathew V Kiang, Elizabeth T Chin, Benjamin Q Huynh, Lloyd A C Chapman, Isabel Rodríguez-Barraquer, Bryan Greenhouse, et al. (+5)
99 [GO] 2021―Mar―20 Navigating post-vaccine COVID-19 futures in the health and economic context C Raina MacIntyre
100 [GO] 2021―Mar―20 Risking further COVID-19 waves despite vaccination Sebastian Contreras, Viola Priesemann
101 [GO] 2021―Mar―20 Vaccination and non-pharmaceutical interventions for COVID-19: a mathematical modelling study Sam Moore, Edward M Hill, Michael J Tildesley, Louise Dyson, Matt J Keeling
102 [GO] 2021―Mar―20 The potential health and economic value of SARS-CoV-2 vaccination alongside physical distancing in the UK: a transmission model-based future scenario analysis and economic evaluation Frank G Sandmann, Nicholas G Davies, Anna Vassall, W John Edmunds, Mark Jit, Fiona Yueqian Sun, et al. (+45)
103 [GO] 2021―Mar―20 Nurses at the frontline of public health emergency preparedness and response: lessons learned from the HIV/AIDS pandemic and emerging infectious disease outbreaks Vincent Guilamo-Ramos, Marco Thimm-Kaiser, Adam Benzekri, Andrew Hidalgo, Yzette Lanier, Sheila Tlou, et al. (+3)
104 [GO] 2021―Mar―11 Alternatives to conventional hospitalisation that enhance health systems' capacity to treat COVID-19 David Nicolás, Emmanuel Coloma, Juan M Pericàs
105 [GO] 2021―Mar―09 Border screening is an essential component of COVID-19 testing strategies in Vanuatu Caroline van Gemert, Posikai Samuel Tapo, Kalkie Sero, Len Tarivonda, Philippe Guyant, Tessa B. Knox, et al. (+10)
106 [GO] 2021―Mar―09 Adjuvantation helps to optimise COVID-19 vaccine candidate Jing-Xin Li, Feng-Cai Zhu
107 [GO] 2021―Mar―09 Chilblain-like acral lesions in long COVID-19: management and implications for understanding microangiopathy Puja Mehta, Christopher B Bunker, Coziana Ciurtin, Joanna C Porter, Rachel C Chambers, Charalampia Papdopoulou, et al. (+6)
108 [GO] 2021―Mar―09 Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial Raches Ella, Siddharth Reddy, Harsh Jogdand, Vamshi Sarangi, Brunda Ganneru, Sai Prasad, et al. (+20)
109 [GO] 2021―Mar―01 Diagnostic dilemma in COVID-19-associated pulmonary aspergillosis Kauser Jabeen, Joveria Farooqi, Muhammad Irfan, Syed Ahsan Ali, David W Denning
110 [GO] 2021―Mar―01 Diagnostic dilemma in COVID-19-associated pulmonary aspergillosis Nitipong Permpalung, Johan Maertens, Kieren A Marr
111 [GO] 2021―Mar―01 Diagnostic dilemma in COVID-19-associated pulmonary aspergillosis - Authors' reply Philipp Koehler, P Lewis White, Paul E Verweij, Oliver A Cornely
112 [GO] 2021―Mar―01 Pandemic psyche Vijay Shankar Balakrishnan
113 [GO] 2021―Feb―24 Anticipating outcomes for patients with COVID-19 and identifying prognosis patterns Michael Darmon, Guillaume Dumas
114 [GO] 2021―Feb―24 Scaling up COVID-19 rapid antigen tests: promises and challenges Rosanna W Peeling, Piero L Olliaro, Debrah I Boeras, Noah Fongwen
115 [GO] 2021―Feb―24 Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study Belén Gutiérrez-Gutiérrez, María Dolores del Toro, Alberto M Borobia, Antonio Carcas, Inmaculada Jarrín, María Yllescas, et al. (+935)
116 [GO] 2021―Feb―24 Bell's palsy and SARS-CoV-2 vaccines Al Ozonoff, Etsuro Nanishi, Ofer Levy
117 [GO] 2021―Feb―24 COVID-19 among American Indians and Alaska Natives Talha Burki
118 [GO] 2021―Feb―24 The world's largest COVID-19 vaccination campaign Sanjeet Bagcchi
119 [GO] 2021―Feb―24 Feelings towards COVID-19 vaccination in Africa Udani Samarasekera
120 [GO] 2021―Feb―23 Importance of non-pharmaceutical interventions in lowering the viral inoculum to reduce susceptibility to infection by SARS-CoV-2 and potentially disease severity Matthew A Spinelli, David V Glidden, Efstathios D Gennatas, Michel Bielecki, Chris Beyrer, George Rutherford, et al. (+3)
121 [GO] 2021―Feb―18 What does 95% COVID-19 vaccine efficacy really mean? Piero Olliaro
122 [GO] 2021―Feb―11 The COVID-19 exit strategy-why we need to aim low The Lancet Infectious Diseases
123 [GO] 2021―Feb―09 CovMT: an interactive SARS-CoV-2 mutation tracker, with a focus on critical variants Intikhab Alam, Aleksandar Radovanovic, Roberto Incitti, Allan A Kamau, Mohammed Alarawi, Esam I Azhar, Takashi Gojobori
124 [GO] 2021―Feb―05 Transmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study Michael Marks, Pere Millat-Martinez, Dan Ouchi, Chrissy h Roberts, Andrea Alemany, Marc Corbacho-Monné, et al. (+12)
125 [GO] 2021―Feb―05 In favour of a bespoke COVID-19 vaccines compensation scheme Duncan Fairgrieve, Søren Holm, Geraint Howells, Claas Kirchhelle, Samantha Vanderslott
126 [GO] 2021―Feb―05 Inactivated COVID-19 vaccines to make a global impact Patrick L Iversen, Sina Bavari
127 [GO] 2021―Feb―05 Understanding the drivers of transmission of SARS-CoV-2 Laura Cornelissen, Emmanuel André
128 [GO] 2021―Feb―05 Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial Zhiwei Wu, Yaling Hu, Miao Xu, Zhen Chen, Wanqi Yang, Zhiwei Jiang, et al. (+9)
129 [GO] 2021―Feb―03 Seroprevalence of anti-SARS-CoV-2 antibodies after the second pandemic peak Silvia Stringhini, María-Eugenia Zaballa, Javier Perez-Saez, Nick Pullen, Carlos de Mestral, Attilio Picazio, et al. (+16)
130 [GO] 2021―Jan―29 Neighbours in time of COVID-19 Rebecca Barksby
131 [GO] 2021―Jan―25 Regulatory approval of COVID-19 vaccine for restricted use in clinical trial mode Prasanta Raghab Mohapatra, Baijayantimala Mishra
132 [GO] 2021―Jan―22 Optimism and caution for an inactivated COVID-19 vaccine Christina A Rostad, Evan J Anderson
133 [GO] 2021―Jan―22 Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial Raches Ella, Krishna Mohan Vadrevu, Harsh Jogdand, Sai Prasad, Siddharth Reddy, Vamshi Sarangi, et al. (+18)
134 [GO] 2021―Jan―20 Structured serological testing is an essential component to investigating SARS-CoV-2 reinfection Scott J C Pallett, Rachael Jones, Paul Randell, Gary W Davies, Luke S P Moore
135 [GO] 2021―Jan―19 Household transmission of SARS-CoV-2 and risk factors for susceptibility and infectivity in Wuhan: a retrospective observational study Fang Li, Yuan-Yuan Li, Ming-Jin Liu, Li-Qun Fang, Natalie E Dean, Gary W K Wong, et al. (+13)
136 [GO] 2021―Jan―19 COVID-19 through the Latinx infectious disease doctor's eyes Annelys Roque Gardner
137 [GO] 2021―Jan―18 Keeping childhood immunisation rates stable during the COVID-19 pandemic Anna A Jarchow-MacDonald, Ruth Burns, Jessica Miller, Linda Kerr, Lorna J Willocks
138 [GO] 2021―Jan―18 Long COVID in the skin: a registry analysis of COVID-19 dermatological duration Devon E McMahon, Antonia E Gallman, George J Hruza, Misha Rosenbach, Jules B Lipoff, Seemal R Desai, et al. (+6)
139 [GO] 2021―Jan―14 First detection of SARS-CoV-2 spike protein N501 mutation in Italy in August, 2020 Simona Fiorentini, Serena Messali, Alberto Zani, Francesca Caccuri, Marta Giovanetti, Massimo Ciccozzi, Arnaldo Caruso
140 [GO] 2021―Jan―09 Multiple testing and the effect of NPIs on the spread of SARS-CoV-2 Christoph Rothe
141 [GO] 2020―Dec―24 Tuberculosis and malaria in the age of COVID-19 The Lancet Infectious Diseases
142 [GO] 2020―Dec―24 Association of tiered restrictions and a second lockdown with COVID-19 deaths and hospital admissions in England: a modelling study Nicholas G Davies, Rosanna C Barnard, Christopher I Jarvis, Timothy W Russell, Malcolm G Semple, Mark Jit, W John Edmunds
143 [GO] 2020―Dec―24 A decentralised point-of-care testing model to address inequities in the COVID-19 response Belinda Hengel, Louise Causer, Susan Matthews, Kirsty Smith, Kelly Andrewartha, Steven Badman, et al. (+10)
144 [GO] 2020―Dec―24 COVID-19 testing in Slovakia Edward Holt
145 [GO] 2020―Dec―24 Equitable distribution of COVID-19 vaccines Talha Burki
146 [GO] 2020―Dec―18 Persistence of IgG response to SARS-CoV-2 Els Duysburgh, Laure Mortgat, Cyril Barbezange, Katelijne Dierick, Natalie Fischer, Leo Heyndrickx, et al. (+6)
147 [GO] 2020―Dec―17 Concerns and motivations about COVID-19 vaccination Rachael H Dodd, Kristen Pickles, Brooke Nickel, Erin Cvejic, Julie Ayre, Carys Batcup, et al. (+6)
148 [GO] 2020―Dec―17 SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study Hossein Poustchi, Maryam Darvishian, Zahra Mohammadi, Amaneh Shayanrad, Alireza Delavari, Ayad Bahadorimonfared, et al. (+36)
149 [GO] 2020―Dec―16 An interactive tracker for ceasefires in the time of COVID-19 John Allison, Sanja Badanjak, Benjamin Bach, Christine Bell, Devanjan Bhattacharya, Fiona Knaussel, Laura Wise
150 [GO] 2020―Dec―16 Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance Philipp Koehler, Matteo Bassetti, Arunaloke Chakrabarti, Sharon C A Chen, Arnaldo Lopes Colombo, Martin Hoenigl, et al. (+16)
151 [GO] 2020―Dec―13 The words that shaped COVID-19 Amesh Adalja
152 [GO] 2020―Dec―09 The granting of emergency use designation to COVID-19 candidate vaccines: implications for COVID-19 vaccine trials Jerome Amir Singh, Ross E G Upshur
153 [GO] 2020―Dec―09 SARS-CoV-2 infection and transmission in educational settings: a prospective, cross-sectional analysis of infection clusters and outbreaks in England Sharif A Ismail, Vanessa Saliba, Jamie Lopez Bernal, Mary E Ramsay, Shamez N Ladhani
154 [GO] 2020―Dec―09 The role of schools and school-aged children in SARS-CoV-2 transmission Stefan Flasche, W John Edmunds
155 [GO] 2020―Dec―07 Fungal infections should be part of the core outcome set for COVID-19 Paul E Verweij, Alexandre Alanio
156 [GO] 2020―Dec―07 Fungal infections should be part of the core outcome set for COVID-19 - Authors' reply John C Marshall, Srinivas Murthy, Janet Diaz
157 [GO] 2020―Dec―07 A public health ethic should inform policies on COVID-19 immunity passports Françoise Baylis, Natalie Kofler
158 [GO] 2020―Dec―07 A public health ethic should inform policies on COVID-19 immunity passports - Authors' reply Rebecca C H Brown, Julian Savulescu, Dominic Kelly, Dominic Wilkinson
159 [GO] 2020―Dec―07 Towards an accurate and systematic characterisation of persistently asymptomatic infection with SARS-CoV-2 Eric A Meyerowitz, Aaron Richterman, Isaac I Bogoch, Nicola Low, Muge Cevik
160 [GO] 2020―Dec―01 Antibiotic prescribing in general practice during COVID-19 Richard Armitage, Laura B Nellums
161 [GO] 2020―Nov―26 The place for remdesivir in COVID-19 treatment Barnaby Young, Thuan Tong Tan, Yee Sin Leo
162 [GO] 2020―Nov―24 A case of SARS-CoV-2 reinfection in Ecuador Belén Prado-Vivar, Mónica Becerra-Wong, Juan José Guadalupe, Sully Márquez, Bernardo Gutierrez, Patricio Rojas-Silva, et al. (+4)
163 [GO] 2020―Nov―21 SARS-CoV-2 and the human-animal interface: outbreaks on mink farms Marion Koopmans
164 [GO] 2020―Nov―20 Kinetics and seroprevalence of SARS-CoV-2 antibodies in children Cathal Roarty, Claire Tonry, Lisa McFetridge, Hannah Mitchell, Chris Watson, Thomas Waterfield, et al. (+23)
165 [GO] 2020―Nov―20 Ct values and infectivity of SARS-CoV-2 on surfaces Günter Kampf, Sebastian Lemmen, Miranda Suchomel
166 [GO] 2020―Nov―19 Expecting the unexpected with COVID-19 vaccines Naor Bar-Zeev, Sonali Kochhar
167 [GO] 2020―Nov―19 Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial Yanjun Zhang, Gang Zeng, Hongxing Pan, Changgui Li, Yaling Hu, Kai Chu, et al. (+14)
168 [GO] 2020―Nov―13 Hydroxychloroquine and COVID-19: a tale of populism and obscurantism Nathan Peiffer-Smadja, Mathieu E Rebeaud, Anthony Guihur, Yahya Mahamat-Saleh, Thibault Fiolet
169 [GO] 2020―Nov―03 Limitations of using mobile phone data to model COVID-19 transmission in the USA Hamada S Badr, Lauren M Gardner
170 [GO] 2020―Nov―03 SARS-CoV-2 seroprevalence and transmission risk factors among high-risk close contacts: a retrospective cohort study Oon Tek Ng, Kalisvar Marimuthu, Vanessa Koh, Junxiong Pang, Kyaw Zaw Linn, Jie Sun, et al. (+19)
171 [GO] 2020―Oct―27 What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2 Susanne H Hodgson, Kushal Mansatta, Garry Mallett, Victoria Harris, Katherine R W Emary, Andrew J Pollard
172 [GO] 2020―Oct―23 Estimating the COVID-19 R number: a bargain with the devil? Chris T Bauch
173 [GO] 2020―Oct―23 The temporal association of introducing and lifting non-pharmaceutical interventions with the time-varying reproduction number (R) of SARS-CoV-2: a modelling study across 131 countries You Li, Harry Campbell, Durga Kulkarni, Alice Harpur, Madhurima Nundy, Xin Wang, Harish Nair
174 [GO] 2020―Oct―19 Estimating the infection-fatality risk of SARS-CoV-2 in New York City during the spring 2020 pandemic wave: a model-based analysis Wan Yang, Sasikiran Kandula, Mary Huynh, Sharon K Greene, Gretchen Van Wye, Wenhui Li, et al. (+6)
175 [GO] 2020―Oct―15 A promising inactivated whole-virion SARS-CoV-2 vaccine Irina Isakova-Sivak, Larisa Rudenko
176 [GO] 2020―Oct―15 Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial Shengli Xia, Yuntao Zhang, Yanxia Wang, Hui Wang, Yunkai Yang, George Fu Gao, et al. (+26)
177 [GO] 2020―Oct―12 What reinfections mean for COVID-19 Akiko Iwasaki
178 [GO] 2020―Oct―12 Genomic evidence for reinfection with SARS-CoV-2: a case study Richard L Tillett, Joel R Sevinsky, Paul D Hartley, Heather Kerwin, Natalie Crawford, Andrew Gorzalski, et al. (+7)
179 [GO] 2020―Oct―09 Beyond COVID-19-a paradigm shift in infection management? Maria J G T Vehreschild, Evelina Tacconelli, Christian G Giske, Andreas Peschel
180 [GO] 2020―Oct―08 China's successful control of COVID-19 Talha Burki
181 [GO] 2020―Oct―08 The intersection of COVID-19 and mental health The Lancet Infectious Diseases
182 [GO] 2020―Oct―06 MERS-CoV in Africa-an enigma with relevance to COVID-19 Stanley Perlman, Alimuddin Zumla
183 [GO] 2020―Oct―06 T-cell responses to MERS coronavirus infection in people with occupational exposure to dromedary camels in Nigeria: an observational cohort study Chris Ka Pun Mok, Airu Zhu, Jingxian Zhao, Eric H Y Lau, Junxiang Wang, Zhao Chen, et al. (+12)
184 [GO] 2020―Oct―06 The role of louse-transmitted diseases in historical plague pandemics Rémi Barbieri, Michel Drancourt, Didier Raoult
185 [GO] 2020―Oct―05 Change in obstetric attendance and activities during the COVID-19 pandemic Asma Khalil, Peter von Dadelszen, Erkan Kalafat, Mercede Sebghati, Shamez Ladhani, Austin Ugwumadu, et al. (+3)
186 [GO] 2020―Oct―05 COVID-19: the deadly threat of misinformation Jane Galvão
187 [GO] 2020―Sep―29 Decarceration and community re-entry in the COVID-19 era Carlos Franco-Paredes, Nazgol Ghandnoosh, Hassan Latif, Martin Krsak, Andres F Henao-Martinez, Megan Robins, et al. (+2)
188 [GO] 2020―Sep―29 Low risk of SARS-CoV-2 transmission by fomites in real-life conditions Mario U Mondelli, Marta Colaneri, Elena M Seminari, Fausto Baldanti, Raffaele Bruno
189 [GO] 2020―Sep―24 COVID-19 claims another victim Talha Burki
190 [GO] 2020―Sep―24 COVID-19 in Africa: half a year later Munyaradzi Makoni
191 [GO] 2020―Sep―24 The complexities of SARS-CoV-2 serology Catherine F Houlihan, Rupert Beale
192 [GO] 2020―Sep―24 Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison Mark Ainsworth, Monique Andersson, Kathryn Auckland, J Kenneth Baillie, Eleanor Barnes, Sally Beer, et al. (+124)
193 [GO] 2020―Sep―21 COVID-19 in malaria-endemic regions: potential consequences for malaria intervention coverage, morbidity, and mortality Miranda I Teboh-Ewungkem, Gideon A Ngwa
194 [GO] 2020―Sep―21 Indirect effects of the COVID-19 pandemic on malaria intervention coverage, morbidity, and mortality in Africa: a geospatial modelling analysis Daniel J Weiss, Amelia Bertozzi-Villa, Susan F Rumisha, Punam Amratia, Rohan Arambepola, Katherine E Battle, et al. (+15)
195 [GO] 2020―Sep―15 Associations between phone mobility data and COVID-19 cases Oliver Gatalo, Katie Tseng, Alisa Hamilton, Gary Lin, Eili Klein
196 [GO] 2020―Sep―14 Intention to vaccinate against COVID-19 in Australia Anthea Rhodes, Monsurul Hoq, Mary-Anne Measey, Margie Danchin
197 [GO] 2020―Sep―11 SARS-CoV-2 transmission via speech-generated respiratory droplets Adriaan Bax, Christina E Bax, Valentyn Stadnytskyi, Philip Anfinrud
198 [GO] 2020―Sep―10 Curing COVID-19 The Lancet Infectious Diseases
199 [GO] 2020―Sep―01 Long-term consequences of COVID-19: research needs Dana Yelin, Eytan Wirtheim, Pauline Vetter, Andre C Kalil, Judith Bruchfeld, Michael Runold, et al. (+9)
200 [GO] 2020―Aug―26 Air travel in the time of COVID-19 The Lancet Infectious Diseases
201 [GO] 2020―Aug―26 The origin of SARS-CoV-2 Talha Burki
202 [GO] 2020―Aug―18 Comparison of molecular testing strategies for COVID-19 control: a mathematical modelling study Nicholas C Grassly, Margarita Pons-Salort, Edward P K Parker, Peter J White, Neil M Ferguson, Kylie Ainslie, et al. (+37)
203 [GO] 2020―Aug―17 COVID-19 and multisystem inflammatory syndrome in children and adolescents Li Jiang, Kun Tang, Mike Levin, Omar Irfan, Shaun K Morris, Karen Wilson, et al. (+2)
204 [GO] 2020―Aug―11 Evolving ethics of COVID-19 challenge trials David Manheim
205 [GO] 2020―Aug―11 COVID-19 pandemic more than a century after the Spanish flu Emilie Javelle, Didier Raoult
206 [GO] 2020―Aug―11 Inclusion of pregnant women in COVID-19 vaccine development Paul T Heath, Kirsty Le Doare, Asma Khalil
207 [GO] 2020―Aug―11 Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics Fabian Standl, Karl-Heinz Jöckel, Bastian Brune, Börge Schmidt, Andreas Stang
208 [GO] 2020―Aug―10 A need for open public data standards and sharing in light of COVID-19 Lauren Gardner, Jeremy Ratcliff, Ensheng Dong, Aaron Katz
209 [GO] 2020―Aug―10 Dental procedure aerosols and COVID-19 Joel B Epstein, Kenneth Chow, Richard Mathias
210 [GO] 2020―Aug―07 SARS-CoV-2 epidemic in African countries-are we losing perspective? Andreas Kalk, Andreas Schultz
211 [GO] 2020―Aug―06 Elimination of COVID-19: what would it look like and is it possible? Anita E Heywood, C Raina Macintyre
212 [GO] 2020―Aug―04 Excess mortality from COVID-19 in an English sentinel network population Mark Joy, F D Richard Hobbs, Dylan McGagh, Oluwafunmi Akinyemi, Simon de Lusignan
213 [GO] 2020―Aug―04 SeroTracker: a global SARS-CoV-2 seroprevalence dashboard Rahul K Arora, Abel Joseph, Jordan Van Wyk, Simona Rocco, Austin Atmaja, Ewan May, et al. (+6)
214 [GO] 2020―Aug―03 Risk of COVID-19 in health-care workers in Denmark: an observational cohort study Kasper Iversen, Henning Bundgaard, Rasmus B Hasselbalch, Jonas H Kristensen, Pernille B Nielsen, Mia Pries-Heje, et al. (+22)
215 [GO] 2020―Aug―03 Using serological data to understand unobserved SARS-CoV-2 risk in health-care settings Adam J Kucharski, Eric J Nilles
216 [GO] 2020―Jul―29 New WHO road map for NTD recovery post COVID-19 Tim Jesudason
217 [GO] 2020―Jul―29 Observations of the global epidemiology of COVID-19 from the prepandemic period using web-based surveillance: a cross-sectional analysis Fatimah S Dawood, Philip Ricks, Gibril J Njie, Michael Daugherty, William Davis, James A Fuller, et al. (+13)
218 [GO] 2020―Jul―29 The indirect impact of COVID-19 on women Talha Burki
219 [GO] 2020―Jul―28 Lung fibrosis: an undervalued finding in COVID-19 pathological series Federica Grillo, Emanuela Barisione, Lorenzo Ball, Luca Mastracci, Roberto Fiocca
220 [GO] 2020―Jul―24 Need for sustainable biobanking networks for COVID-19 and other diseases of epidemic potential Rosanna W Peeling, Debrah Boeras, Annelies Wilder-Smith, Amadou Sall, John Nkengasong
221 [GO] 2020―Jul―23 Monitoring approaches for health-care workers during the COVID-19 pandemic Julia A Bielicki, Xavier Duval, Nina Gobat, Herman Goossens, Marion Koopmans, Evelina Tacconelli, Sylvie van der Werf
222 [GO] 2020―Jul―21 Communicating with children about COVID-19 Fiona Mitchell
223 [GO] 2020―Jul―17 Potential factors linked to high COVID-19 death rates in British minority ethnic groups Marion Cook
224 [GO] 2020―Jul―17 The COVID-19 infodemic The Lancet Infectious Diseases
225 [GO] 2020―Jul―17 Serology testing in the COVID-19 pandemic response Rosanna W Peeling, Catherine J Wedderburn, Patricia J Garcia, Debrah Boeras, Noah Fongwen, John Nkengasong, et al. (+3)
226 [GO] 2020―Jul―14 Rapid implementation of SARS-CoV-2 sequencing to investigate cases of health-care associated COVID-19: a prospective genomic surveillance study Luke W Meredith, William L Hamilton, Ben Warne, Charlotte J Houldcroft, Myra Hosmillo, Aminu S Jahun, et al. (+22)
227 [GO] 2020―Jul―14 COVID-19: from rapid genome sequencing to fast decisions Ole Behrmann, Martin Spiegel
228 [GO] 2020―Jul―14 Serology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland Javier Perez-Saez, Stephen A Lauer, Laurent Kaiser, Simon Regard, Elisabeth Delaporte, Idris Guessous, et al. (+96)
229 [GO] 2020―Jul―14 Challenges and issues of SARS-CoV-2 pool testing Jens N Eberhardt, Nikolas P Breuckmann, Christiane S Eberhardt
230 [GO] 2020―Jul―14 Challenges and issues of SARS-CoV-2 pool testing Baijayantimala Mishra, Bijayini Behera, Monalisa Mohanty, Akshatha Ravindra, Jai Ranjan
231 [GO] 2020―Jul―14 Challenges and issues of SARS-CoV-2 pool testing Jaehyeon Lee, So Yeon Kim, Heungsup Sung, Sang Won Lee, Hyukmin Lee, Kyoung Ho Roh, et al. (+2)
232 [GO] 2020―Jul―14 Challenges and issues of SARS-CoV-2 pool testing - Authors' reply Stefan Lohse, Thorsten Pfuhl, Barbara Berkó-Göttel, Barbara Gärtner, Sören L Becker, Sophie Schneitler, Sigrun Smola
233 [GO] 2020―Jul―06 Assessment of patients who tested positive for COVID-19 after recovery Qi Mei, Jun Li, Ronghui Du, Xianglin Yuan, Ming Li, Jian Li
234 [GO] 2020―Jul―03 Exaggerated risk of transmission of COVID-19 by fomites Emanuel Goldman
235 [GO] 2020―Jul―03 Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics Eskild Petersen, Marion Koopmans, Unyeong Go, Davidson H Hamer, Nicola Petrosillo, Francesco Castelli, et al. (+3)
236 [GO] 2020―Jul―03 Asymptomatic SARS-CoV-2 infection in Belgian long-term care facilities Ana Hoxha, Chloe Wyndham-Thomas, Sofieke Klamer, Dominique Dubourg, Melissa Vermeulen, Naima Hammami, Laura Cornelissen
237 [GO] 2020―Jul―02 COVID-19 in health-care workers in three hospitals in the south of the Netherlands: a cross-sectional study Reina S Sikkema, Suzan D Pas, David F Nieuwenhuijse, Áine O'Toole, Jaco Verweij, Anne van der Linden, et al. (+22)
238 [GO] 2020―Jul―01 Association between mobility patterns and COVID-19 transmission in the USA: a mathematical modelling study Hamada S Badr, Hongru Du, Maximilian Marshall, Ensheng Dong, Marietta M Squire, Lauren M Gardner
239 [GO] 2020―Jun―30 Willingness to vaccinate against COVID-19 in Australia Rachael H Dodd, Erin Cvejic, Carissa Bonner, Kristen Pickles, Kirsten J McCaffery, Julie Ayre, et al. (+6)
240 [GO] 2020―Jun―30 Surfing the COVID-19 scientific wave Mohamed Abbas, Didier Pittet
241 [GO] 2020―Jun―24 COVID-19 in Iran: round 2 Priya Venkatesan
242 [GO] 2020―Jun―24 Stigma during the COVID-19 pandemic Sanjeet Bagcchi
243 [GO] 2020―Jun―24 High COVID-19 testing rate in Portugal Marcia Triunfol
244 [GO] 2020―Jun―24 COVID-19: Playing away the pandemic Vijay Shankar Balakrishnan
245 [GO] 2020―Jun―24 Acute respiratory distress syndrome during a pandemic-an obvious diagnosis? Alexander C Reisinger, Gernot Schilcher, Juergen Prattes, Ines Zollner-Schwetz, Philipp Eller
246 [GO] 2020―Jun―19 Association of mediastinal lymphadenopathy with COVID-19 prognosis Francesco Sardanelli, Andrea Cozzi, Lorenzo Monfardini, Claudio Bnà, Riccardo Alessandro Foà, Angelo Spinazzola, et al. (+4)
247 [GO] 2020―Jun―18 Negative SARS-CoV-2 PCR in patients with chilblain-like lesions Thomas Hubiche, Florence Le Duff, Christine Chiaverini, Valérie Giordanengo, Thierry Passeron
248 [GO] 2020―Jun―17 Household secondary attack rate of COVID-19 and associated determinants in Guangzhou, China: a retrospective cohort study Qin-Long Jing, Ming-Jin Liu, Zhou-Bin Zhang, Li-Qun Fang, Jun Yuan, An-Ran Zhang, et al. (+10)
249 [GO] 2020―Jun―17 Household studies provide key insights on the transmission of, and susceptibility to, SARS-CoV-2 Virginia E Pitzer, Ted Cohen
250 [GO] 2020―Jun―16 Case isolation, contact tracing, and physical distancing are pillars of COVID-19 pandemic control, not optional choices Chandini Raina MacIntyre
251 [GO] 2020―Jun―16 Hydroxychloroquine use in COVID-19: what is the basis for baseline tests? TP Afra, Muhammed Razmi T, Anuradha Bishnoi, NA Bishurul Hafi
252 [GO] 2020―Jun―16 Effectiveness of isolation, testing, contact tracing, and physical distancing on reducing transmission of SARS-CoV-2 in different settings: a mathematical modelling study Adam J Kucharski, Petra Klepac, Andrew J K Conlan, Stephen M Kissler, Maria L Tang, Hannah Fry, et al. (+45)
253 [GO] 2020―Jun―15 Appropriate selection of convalescent plasma donors for COVID-19 Richard S Tedder, Malcolm G Semple
254 [GO] 2020―Jun―15 COVID-19 in Africa: between hope and reality Francine Ntoumi, Thirumalaisamy P Velavan
255 [GO] 2020―Jun―15 Seroconversion in household members of COVID-19 outpatients Rebecca J Cox, Karl A Brokstad, Florian Krammer, Nina Langeland, Bjørn Blomberg, Kanika Kuwelker, et al. (+11)
256 [GO] 2020―Jun―12 A minimal common outcome measure set for COVID-19 clinical research John C Marshall, Srinivas Murthy, Janet Diaz, Neil Adhikari, Derek C Angus, Yaseen M Arabi, et al. (+55)
257 [GO] 2020―Jun―12 Clinical characteristics of COVID-19 in 104 people with SARS-CoV-2 infection on the Diamond Princess cruise ship: a retrospective analysis Sakiko Tabata, Kazuo Imai, Shuichi Kawano, Mayu Ikeda, Tatsuya Kodama, Kazuyasu Miyoshi, et al. (+9)
258 [GO] 2020―Jun―12 Asymptomatic SARS-CoV-2 infection Eng Eong Ooi, Jenny G Low
259 [GO] 2020―Jun―12 SARS-CoV-2 shedding and seroconversion among passengers quarantined after disembarking a cruise ship: a case series Ivan Fan-Ngai Hung, Vincent Chi-Chung Cheng, Xin Li, Anthony Raymond Tam, Derek Ling-Lung Hung, Kelvin Hei-Yeung Chiu, et al. (+26)
260 [GO] 2020―Jun―11 Political casualties of the COVID-19 pandemic The Lancet Infectious Diseases
261 [GO] 2020―Jun―08 Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study Luca Carsana, Aurelio Sonzogni, Ahmed Nasr, Roberta Simona Rossi, Alessandro Pellegrinelli, Pietro Zerbi, et al. (+9)
262 [GO] 2020―Jun―08 Pathologists in pursuit of the COVID-19 culprit Eunhee S Yi, Matthew J Cecchini, Melanie C Bois
263 [GO] 2020―Jun―02 COVID-19 and essential pregnant worker policies Elizabeth S McDonald
264 [GO] 2020―May―29 COVID-19 human challenge studies: ethical issues Euzebiusz Jamrozik, Michael J Selgelid
265 [GO] 2020―May―28 COVID-19 and the difficulty of inferring epidemiological parameters from clinical data Simon N Wood, Ernst C Wit, Matteo Fasiolo, Peter J Green
266 [GO] 2020―May―28 COVID-19 and the difficulty of inferring epidemiological parameters from clinical data - Authors' reply Robert Verity, Lucy Okell, Ilaria Dorigatti, Peter Winskill, Charlie Whittaker, Patrick Walker, et al. (+3)
267 [GO] 2020―May―28 Implication of SARS-CoV-2 evolution in the sensitivity of RT-qPCR diagnostic assays Nuno Sampaio Osório, Margarida Correia-Neves
268 [GO] 2020―May―27 Death threats after a trial on chloroquine for COVID-19 Estella Ektorp
269 [GO] 2020―May―27 Obstacles to COVID-19 control in east Africa Esther Nakkazi
270 [GO] 2020―May―27 COVID-19 lockdown of Roma settlements in Slovakia Ed Holt
271 [GO] 2020―May―22 Hydroxychloroquine prophylaxis for high-risk COVID-19 contacts in India: a prudent approach Praveen Tilangi, Devashish Desai, Adil Khan, Manish Soneja
272 [GO] 2020―May―21 A future vaccination campaign against COVID-19 at risk of vaccine hesitancy and politicisation Patrick Peretti-Watel, Valérie Seror, Sébastien Cortaredona, Odile Launay, Jocelyn Raude, Pierrea Verger, et al. (+6)
273 [GO] 2020―May―21 Individual quarantine versus active monitoring of contacts for the mitigation of COVID-19: a modelling study Corey M Peak, Rebecca Kahn, Yonatan H Grad, Lauren M Childs, Ruoran Li, Marc Lipsitch, Caroline O Buckee
274 [GO] 2020―May―21 COVID-19: when should quarantine be enforced? Chris T Bauch, Madhur Anand
275 [GO] 2020―May―21 RT-PCR for SARS-CoV-2: quantitative versus qualitative Mi Seon Han, Jung-Hyun Byun, Yonggeun Cho, John Hoon Rim
276 [GO] 2020―May―20 Tale of three seeding patterns of SARS-CoV-2 in Saudi Arabia Ziad A Memish, Nawfal Aljerian, Shahul H Ebrahim
277 [GO] 2020―May―18 COVID-19 screening of health-care workers in a London maternity hospital Asma Khalil, Robert Hill, Shamez Ladhani, Katherine Pattisson, Pat O'Brien
278 [GO] 2020―May―18 Silent COVID-19: what your skin can reveal Claudio Guarneri, Emmanuele Venanzi Rullo, Piero Pavone, Massimiliano Berretta, Manuela Ceccarelli, Alfonso Natale, Giuseppe Nunnari
279 [GO] 2020―May―16 The UK hibernated pandemic influenza research portfolio: triggered for COVID-19 Colin R Simpson, Benjamin D Thomas, Kirsty Challen, Daniela De Angelis, Ellen Fragaszy, Steve Goodacre, et al. (+5)
280 [GO] 2020―May―16 Toward a clinically based classification of disease severity for paediatric COVID-19 Danilo Buonsenso, Niccolò Parri, Cristina De Rose, Piero Valentini
281 [GO] 2020―May―16 Toward a clinically based classification of disease severity for paediatric COVID-19 - Authors' reply Dong Chen, Feng Tang, Shushu Lu, Qifa Song
282 [GO] 2020―May―16 Investigation of a COVID-19 outbreak in Germany resulting from a single travel-associated primary case: a case series Merle M Böhmer, Udo Buchholz, Victor M Corman, Martin Hoch, Katharina Katz, Durdica V Marosevic, et al. (+35)
283 [GO] 2020―May―16 Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study Simon de Lusignan, Jienchi Dorward, Ana Correa, Nicholas Jones, Oluwafunmi Akinyemi, Gayatri Amirthalingam, et al. (+16)
284 [GO] 2020―May―16 Importance of precise data on SARS-CoV-2 transmission dynamics control Jan Rybniker, Gerd Fätkenheuer
285 [GO] 2020―May―16 Who is most likely to be infected with SARS-CoV-2? Rachel E Jordan, Peymane Adab
286 [GO] 2020―May―07 Prevention of the cytokine storm in COVID-19 David J M Wright
287 [GO] 2020―May―07 Dearth of infectious diseases physicians as the USA faces a global pandemic Syed M Qasim Hussaini
288 [GO] 2020―May―06 COVID-19 in Cameroon: a crucial equation to resolve Francois-Xavier Mbopi-Keou, Jean-Emmanuel Pondi, Maurice Aurelien Sosso
289 [GO] 2020―May―06 COVID-19 on the African continent Chad R Wells, Jason K Stearns, Pascal Lutumba, Alison P Galvani
290 [GO] 2020―May―06 Testing COVID-19 therapies to prevent progression of mild disease Marc Lipsitch, Stanley Perlman, Matthew K Waldor
291 [GO] 2020―Apr―30 Hypoxaemia related to COVID-19: vascular and perfusion abnormalities on dual-energy CT Min Lang, Avik Som, Dexter P Mendoza, Efren J Flores, Nicholas Reid, Denston Carey, et al. (+5)
292 [GO] 2020―Apr―29 Progressive respiratory failure in COVID-19: a hypothesis Henrik Endeman, Philip van der Zee, Michel E van Genderen, Johannes P C van den Akker, Diederik Gommers
293 [GO] 2020―Apr―28 Pooling of samples for testing for SARS-CoV-2 in asymptomatic people Stefan Lohse, Thorsten Pfuhl, Barbara Berkó-Göttel, Jürgen Rissland, Tobias Geißler, Barbara Gärtner, et al. (+3)
294 [GO] 2020―Apr―27 Estimation of COVID-19 burden in Egypt Mohamed Hassany, Wael Abdel-Razek, Noha Asem, Mohamed AbdAllah, Hala Zaid
295 [GO] 2020―Apr―27 Estimation of COVID-19 burden in Egypt Tarek Sahmoud
296 [GO] 2020―Apr―27 Estimation of COVID-19 burden in Egypt Khaled Elmeleegy
297 [GO] 2020―Apr―27 Estimation of COVID-19 burden in Egypt Ahmed Negida
298 [GO] 2020―Apr―27 Estimation of COVID-19 burden in Egypt - Authors' reply Ashleigh R Tuite, Victoria Ng, Erin Rees, David Fisman, Annelies Wilder-Smith, Kamran Khan, Isaac I Bogoch
299 [GO] 2020―Apr―27 Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study Qifang Bi, Yongsheng Wu, Shujiang Mei, Chenfei Ye, Xuan Zou, Zhen Zhang, et al. (+16)
300 [GO] 2020―Apr―27 Impact of contact tracing on SARS-CoV-2 transmission Kaiyuan Sun, Cécile Viboud
301 [GO] 2020―Apr―22 No SARS-CoV-2 detected in amniotic fluid in mid-pregnancy Nan Yu, Wei Li, Qingling Kang, Wanjiang Zeng, Ling Feng, Jianli Wu
302 [GO] 2020―Apr―21 Mediastinal lymphadenopathy in patients with severe COVID-19 Xavier Valette, Damien du Cheyron, Suzanne Goursaud
303 [GO] 2020―Apr―21 Plea for multitargeted interventions for severe COVID-19 Benjamin Jean Gaborit, Jean-François Bergmann, Cristina Mussini, Jose Ramon Arribas, Georg Behrens, Sharon Walmsley, et al. (+2)
304 [GO] 2020―Apr―21 The important role of serology for COVID-19 control Amy K Winter, Sonia T Hegde
305 [GO] 2020―Apr―21 Targeting COVID-19 interventions towards migrants in humanitarian settings Sally Hargreaves, Dominik Zenner, Kolitha Wickramage, Anna Deal, Sally E Hayward
306 [GO] 2020―Apr―21 Projecting the demand for ventilators at the peak of the COVID-19 outbreak in the USA Chad R Wells, Meagan C Fitzpatrick, Pratha Sah, Affan Shoukat, Abhishek Pandey, Abdulrahman M El-Sayed, et al. (+3)
307 [GO] 2020―Apr―21 Connecting clusters of COVID-19: an epidemiological and serological investigation Sarah Ee Fang Yong, Danielle Elizabeth Anderson, Wycliffe E Wei, Junxiong Pang, Wan Ni Chia, Chee Wah Tan, et al. (+14)
308 [GO] 2020―Apr―21 Two Middle East respiratory syndrome vaccines: first step for other coronavirus vaccines? Kayvon Modjarrad, Jerome H Kim
309 [GO] 2020―Apr―21 Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial Pedro M Folegatti, Mustapha Bittaye, Amy Flaxman, Fernando Ramos Lopez, Duncan Bellamy, Alexandra Kupke, et al. (+24)
310 [GO] 2020―Apr―21 Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial Till Koch, Christine Dahlke, Anahita Fathi, Alexandra Kupke, Verena Krähling, Nisreen M A Okba, et al. (+19)
311 [GO] 2020―Apr―17 Chloroquine or hydroxychloroquine for prophylaxis of COVID-19 Nicola Principi, Susanna Esposito
312 [GO] 2020―Apr―17 Hydroxychloroquine prophylaxis for COVID-19 contacts in India Sahaj Rathi, Pranav Ish, Ashwini Kalantri, Shriprakash Kalantri
313 [GO] 2020―Apr―17 Gaps in India's preparedness for COVID-19 control Patralekha Chetterje
314 [GO] 2020―Apr―17 COVID-19 disrupts vaccine delivery Roxanne Nelson
315 [GO] 2020―Apr―17 COVID-19 in Latin America Talha Burki
316 [GO] 2020―Apr―17 Rural areas at risk during COVID-19 pandemic Peter Ranscombe
317 [GO] 2020―Apr―17 COVID-19: endgames The Lancet Infectious Diseases
318 [GO] 2020―Apr―16 Protecting workers aged 60-69 years from COVID-19 Judith R Glynn
319 [GO] 2020―Apr―15 Smell and taste dysfunction in patients with COVID-19 Michael S Xydakis, Puya Dehgani-Mobaraki, Eric H Holbrook, Urban W Geisthoff, Christian Bauer, Charlotte Hautefort, et al. (+4)
320 [GO] 2020―Apr―15 Utility of hyposmia and hypogeusia for the diagnosis of COVID-19 François Bénézit, Paul Le Turnier, Charles Declerck, Cécile Paillé, Matthieu Revest, Vincent Dubée, et al. (+30)
321 [GO] 2020―Apr―15 COVID-19 and the coming epidemic in US immigration detention centres Jaimie P Meyer, Carlos Franco-Paredes, Parveen Parmar, Faiza Yasin, Matthew Gartland
322 [GO] 2020―Apr―09 A Spanish-translated clinical algorithm for management of suspected SARS-CoV-2 infection in pregnant women Raigam J Martinez-Portilla, Anna Goncé, Ameth Hawkins-Villarreal, Francesc Figueras
323 [GO] 2020―Apr―08 Making decisions to mitigate COVID-19 with limited knowledge Weituo Zhang, Bi-yun Qian
324 [GO] 2020―Apr―08 Invisible spread of SARS-CoV-2 Nian Xiong, Tao Wang, Zhicheng Lin
325 [GO] 2020―Apr―08 Invisible spread of SARS-CoV-2 - Authors' reply Adam J Kucharski, Rosalind M Eggo
326 [GO] 2020―Apr―04 Baricitinib for COVID-19: a suitable treatment? Ennio G Favalli, Martina Biggioggero, Gabriella Maioli, Roberto Caporali
327 [GO] 2020―Apr―04 Baricitinib for COVID-19: a suitable treatment? - Authors' reply Peter J Richardson, Mario Corbellino, Justin Stebbing
328 [GO] 2020―Apr―03 From China: hope and lessons for COVID-19 control Andrew S Azman, Francisco J Luquero
329 [GO] 2020―Apr―02 Evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside Hubei province, China: a descriptive and modelling study Juanjuan Zhang, Maria Litvinova, Wei Wang, Yan Wang, Xiaowei Deng, Xinghui Chen, et al. (+18)
330 [GO] 2020―Apr―01 Using observational data to quantify bias of traveller-derived COVID-19 prevalence estimates in Wuhan, China Rene Niehus, Pablo M De Salazar, Aimee R Taylor, Marc Lipsitch
331 [GO] 2020―Apr―01 Modelling COVID-19 transmission: from data to intervention Zhongwei Jia, Zuhong Lu
332 [GO] 2020―Mar―31 Estimating case fatality rates of COVID-19 David Dongkyung Kim, Akash Goel
333 [GO] 2020―Mar―31 Estimating case fatality rates of COVID-19 Marc Lipsitch
334 [GO] 2020―Mar―31 Estimating case fatality rates of COVID-19 Piotr Spychalski, Agata Błażyńska-Spychalska, Jarek Kobiela
335 [GO] 2020―Mar―31 SARS-CoV-2: a time for clear and immediate action Gregory A Poland
336 [GO] 2020―Mar―30 Likelihood of survival of coronavirus disease 2019 Shigui Ruan
337 [GO] 2020―Mar―30 Estimates of the severity of coronavirus disease 2019: a model-based analysis Robert Verity, Lucy C Okell, Ilaria Dorigatti, Peter Winskill, Charles Whittaker, Natsuko Imai, et al. (+27)
338 [GO] 2020―Mar―30 Will financial innovation transform pandemic response? Susan L Erikson, Leigh Johnson
339 [GO] 2020―Mar―27 The many estimates of the COVID-19 case fatality rate Dimple D Rajgor, Meng Har Lee, Sophia Archuleta, Natasha Bagdasarian, Swee Chye Quek
340 [GO] 2020―Mar―27 Clinical and virological data of the first cases of COVID-19 in Europe: a case series Francois-Xavier Lescure, Lila Bouadma, Duc Nguyen, Marion Parisey, Paul-Henri Wicky, Sylvie Behillil, et al. (+17)
341 [GO] 2020―Mar―27 Understanding COVID-19: what does viral RNA load really mean? Gavin M Joynt, William KK Wu
342 [GO] 2020―Mar―26 US public health budget cuts in the face of COVID-19 Sharmila Devi
343 [GO] 2020―Mar―26 Estimation of the COVID-19 burden in Egypt through exported case detection Ashleigh R Tuite, Victoria Ng, Erin Rees, David Fisman, Annelies Wilder-Smith, Kamran Khan, Isaac I Bogoch
344 [GO] 2020―Mar―26 CT screening for early diagnosis of SARS-CoV-2 infection Yongshun Huang, Weibin Cheng, Na Zhao, Hongying Qu, Junzhang Tian
345 [GO] 2020―Mar―26 CT screening for early diagnosis of SARS-CoV-2 infection - Authors' reply Heshui Shi, Xiaoyu Han, Yukun Cao, Osamah Alwalid, Chuansheng Zheng
346 [GO] 2020―Mar―25 COVID-19 in children: the link in the transmission chain Alyson A Kelvin, Scott Halperin
347 [GO] 2020―Mar―25 Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study Haiyan Qiu, Junhua Wu, Liang Hong, Yunling Luo, Qifa Song, Dong Chen
348 [GO] 2020―Mar―24 Management of pregnant women infected with COVID-19 Yongwen Luo, Kai Yin
349 [GO] 2020―Mar―24 Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: a retrospective, single-centre, descriptive study Nan Yu, Wei Li, Qingling Kang, Zhi Xiong, Shaoshuai Wang, Xingguang Lin, et al. (+8)
350 [GO] 2020―Mar―23 Scientific and ethical basis for social-distancing interventions against COVID-19 Joseph A Lewnard, Nathan C Lo
351 [GO] 2020―Mar―23 COVID-19 and medical education Hanad Ahmed, Mohammed Allaf, Hussein Elghazaly
352 [GO] 2020―Mar―23 The first COVID-19 case in Afghanistan acquired from Iran Sayed H Mousavi, Jaffer Shah, Hoang T N Giang, Tareq M A Al-Ahdal, Shafi U Zahid, Fardina Temory, et al. (+3)
353 [GO] 2020―Mar―23 Interventions to mitigate early spread of SARS-CoV-2 in Singapore: a modelling study Joel R Koo, Alex R Cook, Minah Park, Yinxiaohe Sun, Haoyang Sun, Jue Tao Lim, et al. (+2)
354 [GO] 2020―Mar―23 Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study Kelvin Kai-Wang To, Owen Tak-Yin Tsang, Wai-Shing Leung, Anthony Raymond Tam, Tak-Chiu Wu, David Christopher Lung, et al. (+19)
355 [GO] 2020―Mar―23 SARS-CoV-2: virus dynamics and host response Yu Chen, Lanjuan Li
356 [GO] 2020―Mar―19 Viral dynamics in mild and severe cases of COVID-19 Yang Liu, Li-Meng Yan, Lagen Wan, Tian-Xin Xiang, Aiping Le, Jia-Ming Liu, et al. (+3)
357 [GO] 2020―Mar―19 Estimation of COVID-19 outbreak size in Italy Ashleigh R Tuite, Victoria Ng, Erin Rees, David Fisman
358 [GO] 2020―Mar―17 COVID-19 in pregnant women Manuel B Schmid, Jehudith Fontijn, Nicole Ochsenbein-Kölble, Christoph Berger, Dirk Bassler
359 [GO] 2020―Mar―17 COVID-19 in pregnant women - Authors' reply David Baud, Eric Giannoni, Léo Pomar, Xiaolong Qi, Karin Nielsen-Saines, Didier Musso, Guillaume Favre
360 [GO] 2020―Mar―17 Disease X: accelerating the development of medical countermeasures for the next pandemic Shmona Simpson, Michael C Kaufmann, Vitaly Glozman, Ajoy Chakrabarti
361 [GO] 2020―Mar―13 COVID-19, a pandemic or not? The Lancet Infectious Diseases
362 [GO] 2020―Mar―12 Real estimates of mortality following COVID-19 infection David Baud, Xiaolong Qi, Karin Nielsen-Saines, Didier Musso, Léo Pomar, Guillaume Favre
363 [GO] 2020―Mar―12 SARS-CoV-2 RNA more readily detected in induced sputum than in throat swabs of convalescent COVID-19 patients Huanqin Han, Qingfeng Luo, Fan Mo, Lieming Long, Weiqiang Zheng
364 [GO] 2020―Mar―12 Early dynamics of transmission and control of COVID-19: a mathematical modelling study Adam J Kucharski, Timothy W Russell, Charlie Diamond, Yang Liu, John Edmunds, Sebastian Funk, et al. (+16)
365 [GO] 2020―Mar―09 Covert COVID-19 and false-positive dengue serology in Singapore Gabriel Yan, Chun Kiat Lee, Lawrence T M Lam, Benedict Yan, Ying Xian Chua, Anita Y N Lim, et al. (+9)
366 [GO] 2020―Mar―09 Outbreak investigation for COVID-19 in northern Vietnam Hai Nguyen Thanh, Truong Nguyen Van, Huong Ngo Thi Thu, Binh Nghiem Van, Binh Doan Thanh, Ha Phung Thi Thu, et al. (+5)
367 [GO] 2020―Mar―09 COVID-19 with spontaneous pneumomediastinum Changyu Zhou, Chen Gao, Yuanliang Xie, Maosheng Xu
368 [GO] 2020―Mar―05 Taking the right measures to control COVID-19 Yonghong Xiao, Mili Estee Torok
369 [GO] 2020―Mar―05 Can we contain the COVID-19 outbreak with the same measures as for SARS? Annelies Wilder-Smith, Calvin J Chiew, Vernon J Lee
370 [GO] 2020―Mar―03 Guidelines for pregnant women with suspected SARS-CoV-2 infection Guillaume Favre, Léo Pomar, Xiaolong Qi, Karin Nielsen-Saines, Didier Musso, David Baud
371 [GO] 2020―Feb―29 A family cluster of SARS-CoV-2 infection involving 11 patients in Nanjing, China Rui Huang, Juan Xia, Yuxin Chen, Chun Shan, Chao Wu
372 [GO] 2020―Feb―27 Convalescent plasma as a potential therapy for COVID-19 Long Chen, Jing Xiong, Lei Bao, Yuan Shi
373 [GO] 2020―Feb―27 COVID-19: combining antiviral and anti-inflammatory treatments Justin Stebbing, Anne Phelan, Ivan Griffin, Catherine Tucker, Olly Oechsle, Dan Smith, Peter Richardson
374 [GO] 2020―Feb―25 Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study Heshui Shi, Xiaoyu Han, Nanchuan Jiang, Yukun Cao, Osamah Alwalid, Jin Gu, et al. (+2)
375 [GO] 2020―Feb―25 COVID-19 pneumonia: what has CT taught us? Elaine Y P Lee, Ming-Yen Ng, Pek-Lan Khong
376 [GO] 2020―Feb―25 Viral load of SARS-CoV-2 in clinical samples Yang Pan, Daitao Zhang, Peng Yang, Leo L M Poon, Quanyi Wang
377 [GO] 2020―Feb―19 The first Vietnamese case of COVID-19 acquired from China Le Van Cuong, Hoang Thi Nam Giang, Le Khac Linh, Jaffer Shah, Le Van Sy, Trinh Huu Hung, et al. (+4)
378 [GO] 2020―Feb―19 An interactive web-based dashboard to track COVID-19 in real time Ensheng Dong, Hongru Du, Lauren Gardner
379 [GO] 2020―Feb―19 Open access epidemiological data from the COVID-19 outbreak Bo Xu, Moritz U G Kraemer, Bo Xu, Bernardo Gutierrez, Sumiko Mekaru, Kara Sewalk, et al. (+14)
380 [GO] 2020―Feb―19 Initiation of a new infection control system for the COVID-19 outbreak Xuejiao Chen, Junzhang Tian, Guanming Li, Guowei Li
381 [GO] 2020―Feb―19 Asymptomatic cases in a family cluster with SARS-CoV-2 infection Xingfei Pan, Dexiong Chen, Yong Xia, Xinwei Wu, Tangsheng Li, Xueting Ou, et al. (+2)
382 [GO] 2020―Feb―17 Challenges of coronavirus disease 2019 The Lancet Infectious Diseases
383 [GO] 2020―Feb―17 Outbreak of coronavirus disease 2019 Talha Burki
384 [GO] 2020―Feb―10 The first 2019 novel coronavirus case in Nepal Anup Bastola, Ranjit Sah, Alfonso J Rodriguez-Morales, Bibek Kumar Lal, Runa Jha, Hemant Chanda Ojha, et al. (+6)
385 [GO] 2020―Feb―07 Game consumption and the 2019 novel coronavirus Jie Li, Jun Li, Xiaoru Xie, Xiaomei Cai, Jian Huang, Xuemei Tian, Hong Zhu
386 [GO] 2020―Feb―07 Pandemic potential of 2019-nCoV Robin Thompson
387 [GO] 2020―Jan―21 Oral influenza vaccination-a possible solution for the next pandemic? Larisa Rudenko, Irina Isakova-Sivak
388 [GO] 2019―Dec―10 Stories of the 1918 influenza pandemic and its legacy Marta Gritti

[de][en]

Last change 2021―Sep―04 16:13:39 UTC

© Daten-Quadrat 2021       Done in 0.121 sec